TERN vs VRTX · $6.12B cap vs P/E 30, rev $12.00B
Terns Pharmaceuticals Inc (TERN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
TERN currently screens at market cap $6.12B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the TERN and VRTX stock pages for the full models.
Not investment advice.